26 July 2017 in Journal of Cardiovascular Electrophysiology
18 February 2026 in JACC: Case Reports
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited disorder characterized by fibrofatty replacement of the right ventricular myocardium. Anthracycline-induced cardiotoxicity typically manifests as left ventricular dysfunction; however, we present a unique case of an acquired ARVC phenotype secondary to anthracycline chemotherapy exposure. A 74-year-old man developed recurrent exertional syncope 8 months after completing rituximab, cyclophosphamide, hydroxydaunorubicin (an anthracycline that is also known as doxorubicin), oncovin, and prednisone chemotherapy. He met 3 major 2010 Revised Task Force Criteria for definite ARVC, despite negative genetic testing and absence of family history. He underwent dual-chamber implantable cardioverter-defibrillator implantation with complete resolution of syncopal episodes. Recognition of acquired ARVC after anthracycline exposure broadens the spectrum of chemotherapy-related cardiomyopathies and calls for vigilance in patients with unexplained right ventricular dysfunction or arrhythmias after chemotherapy. Anthracyclines may cause isolated right ventricular dysfunction mimicking ARVC. Clinicians should maintain vigilance for right ventricular dysfunction or arrhythmias in patients after anthracycline therapy.
16 May 2023 in Journal of Arrhythmia
This spotlight article gives two clinical case examples for the implementation of a suggested safe and feasible strategy to implant leadless pacemakers instead of changing the generators of transvenous pacemakers with depleted batteries in elderly patients.
25 October 2025 in JACC: Clinical Electrophysiology
12 June 2023 in JACC: Case Reports
Transvenous pacemakers may lead to wound site complications, such as hematomas and infections. Leadless pacemakers have eliminated these risks. However, when the central venous and/or cardiac anatomy are challenging, their implantation technique may require modification(s). Here, we discuss 3 cases of successful leadless pacemaker implantation in patients with a challenging anatomy. (Level of Difficulty: Advanced.)